Patents by Inventor Olga Bandman

Olga Bandman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Secreted proteins
    Publication number: 20070092885
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: March 20, 2006
    Publication date: April 26, 2007
    Inventors: Henry Yue, Monique Yao, Ameena Gandhi, Mariah Baughn, Anita Swarnakar, Narinder Chawla, Madhusudan Sanjanwala, Michael Thornton, Vicki Elliott, Yan Lu, Kimberly Gietzen, Neil Burford, Li Ding, April Hafalia, Y. Tang, Olga Bandman, Bridget Warren, Cynthia Honchell, Dyung Lu, Kavitha Thangavelu, Sally Lee, Yuming Xu, Junming Yang, Preeti Lal, Bao Tran, Craig Ison, Brendan Duggan, Stephanie Sapperstein
  • Secreted proteins
    Publication number: 20070087342
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: January 10, 2001
    Publication date: April 19, 2007
    Applicant: Incyte Corporation
    Inventor: Olga Bandman
  • Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them
    Publication number: 20070078260
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2- encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2 -encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Application
    Filed: November 27, 2006
    Publication date: April 5, 2007
    Inventors: Roger Coleman, Olga Bandman, Craig Wilde
  • Human transmembrane proteins
    Publication number: 20070054312
    Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.
    Type: Application
    Filed: November 8, 2006
    Publication date: March 8, 2007
    Inventors: Y. Tang, Preeti Lal, Jennifer Hillman, Henry Yue, Karl Guegler, Neil Corley, Olga Bandman, Chandra Patterson, Gina Gorgone, Matthew Kaser, Mariah Baughn, Janice Au-Young
  • NOVEL HUMAN SODIUM-DEPENDENT PHOSPHATE COTRANSPORTER
    Publication number: 20070026449
    Abstract: The present invention provides a human sodium-dependent phosphate cotransporter (NAPTR) and polynucleotides which identify and encode NAPTR. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NAPTR and a method for producing NAPTR. The invention also provides for agonists, antibodies, or antagonists specifically for NAPTR. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NAPTR for the treatment of diseases associated with the expression of NAPTR. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NAPTR. The invention also provides a method for treating disorders associated with decreased phosphate levels by administering NAPTR and a method for treating disorders associated with increased phosphate levels by administering antagonists to NAPTR.
    Type: Application
    Filed: September 25, 2006
    Publication date: February 1, 2007
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Preeti Lal, Olga Bandman
  • Human cAMP-dependent protein kinase beta-catalytic subunit
    Patent number: 7112426
    Abstract: The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: September 26, 2006
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Danniel B Nguyen, Narinder K Chawla, April J A Hafalia, Monique G Yao, Ameena R Gandhi, Rajagopal Gururajan, Li Ding, Chandra S Arvizu, Henry Yue, Mariah R Baughn, Catherine M Tribouley, Michael B Thornton, Vicki S Elliott, Yan Lu, Craig H Ison, Janice K Au-Young, Y Tom Tang, Yalda Azimzai, John D Burrill, Gregory A Marcus, Kurt A Zingler, Dyung Aina M Lu, Preeti G Lai, Jayalaxmi Ramkumar, Bridget A Warren, Liam Kearney, Jennifer L Policky, Kavitha Thangavelu, Neil Burford
  • Human protease molecules
    Patent number: 7045333
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: May 16, 2006
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah
  • Human protein phosphatase 2C
    Patent number: 7029897
    Abstract: The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: April 18, 2006
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Li Ding, Preeti G. Lal, Jennifer A. Griffin, Rajagopal Gururajan, Mariah R. Baughn, Craig H. Ison, Jayalaxmi Ramkumar, Catherine M. Tribouley, Anita Swarnakar, Neil Burford, Olga Bandman, Michael Thornton, Farrah A. Khan, Narinder K. Chawla, Danniel B. Nguyen, Vicki S. Elliott, Yuming Xu, Yan Lu, April J. A. Hafalia, Monique G. Yao, Ameena R. Gandhi, Chandra S. Arvizu, Ian J. Forsythe
  • Human cathepsin
    Publication number: 20060063249
    Abstract: The invention provides a new human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of LCAP.
    Type: Application
    Filed: September 12, 2003
    Publication date: March 23, 2006
    Applicant: Incyte Corporation
    Inventors: Olga Bandman, Karl Guegler, Neil Corley, Purvi Shah
  • Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
    Patent number: 7005509
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: February 28, 2006
    Assignee: Incyte Corporation
    Inventors: Roger Coleman, Olga Bandman, Craig G. Wilde
  • Human protease molecules
    Publication number: 20050282214
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Application
    Filed: July 19, 2005
    Publication date: December 22, 2005
    Inventors: Olga Bandman, Jennifer Hillman, Henry Yue, Karl Guegler, Neil Corley, Y. Tang, Purvi Shah
  • Proteases and protease inhibitors
    Publication number: 20050260708
    Abstract: The invention provides human proteases and protease inhibitors (PPIM) and polynucleotides which identify and encode PPIM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PPIM.
    Type: Application
    Filed: March 4, 2005
    Publication date: November 24, 2005
    Inventors: Henry Yue, Preeti Lal, Y. Tang, Olga Bandman, Mariah Baughn, Yalda Azimzai, Dyung Aina Lu, Junming Yang
  • Cell signaling proteins
    Publication number: 20050260644
    Abstract: The invention provides human cell signaling proteins (CSIGP) and polynucleotides which identify and encode CSIGP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or prevention disorders associated with expression of CSIGP.
    Type: Application
    Filed: April 6, 2005
    Publication date: November 24, 2005
    Inventors: Olga Bandman, Jennifer Hillman, Preeti Lal, Henry Yue, Y. Tang, Chandra Patterson, Mariah Baughn, Junming Yang
  • Microtubule-associated proteins and tubulins
    Patent number: 6962799
    Abstract: The invention provides human microtubule-associated proteins and tubulins (MICAPTUB) and polynucleotides which identify and encode MICAPTUB. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MICAPTUB.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: November 8, 2005
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Danniel B. Nguyen, Catherine M. Tribouley, Olga Bandman, Y. Tom Tang, Preeti G. Lal, Narinder K. Chawla, Jennifer L. Policky
  • Human transcriptional regulator molecules
    Publication number: 20050214795
    Abstract: The invention provides human transcriptional regulator molecules (HTRM) and polynucleotides which identify and encode HTRM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HTRM.
    Type: Application
    Filed: October 26, 2004
    Publication date: September 29, 2005
    Inventors: Jennifer Hillman, Olga Bandman, Preeti Lal, Henry Yue, Roopa Reddy, Y. Tang, Edward Gerstin, Chandra Arvizu, Mariah Baughn, Yalda Azimzai, Dyung M. Lu
  • Kinases and phosphatases
    Publication number: 20050186568
    Abstract: Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.
    Type: Application
    Filed: October 17, 2002
    Publication date: August 25, 2005
    Inventors: Olga Bandman, Mariah Baughn, Shanya Becha, Mark Borowsky, Brendan Duggan, Brooke Emerling, Ian Forsythe, Ameena Ganhi, Jennifer Griffin, Rajagopal Gururajan, April Hafalia, Farrah Khan, Preeti Lal, Ernestine Lee, Soo Lee, Erika Lindquist, Dyung Aina Lu, Yan Lu, Joseph Marquis, Danniel Nguyen, Chandra Arvizu, Jayalaxmi Ramkumar, Shirley Recipon, Thomas Richardson, Anita Swarnakar, Y.Tom Tang, Michael Thornton, Uyen Tran, Narinder Chawla, Bridget Warren, Junming Yang, Monique Yao, Henry Yue, Yeganeh Zebarjadian
  • Drug metabolizing enzymes
    Publication number: 20050181415
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: March 14, 2005
    Publication date: August 18, 2005
    Inventors: Junming Yang, Mariah Baughn, Neil Burford, Janice Au-Young, Dyung Lu, Roopa Reddy, Huijun Ring, Jennifer Hillman, Henry Yue, Yalda Azimzai, Monique Yao, Ameena Gandhi, Danniel Nguyen, Y. Tang, Preeti Lal, Olga Bandman
  • Human protease molecules
    Publication number: 20050181404
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Application
    Filed: January 27, 2005
    Publication date: August 18, 2005
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer Hillman, Henry Yue, Karl Guegler, Neil Corley, Y. Tang, Purvi Shah
  • Prostate associated Ets protein
    Patent number: 6919429
    Abstract: The invention provides a human prostate associated Ets protein (PRAEP) and polynucleotides which identify and encode PRAEP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PRAEP.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: July 19, 2005
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Karl J. Guegler, Preeti Lal, Neil C. Corley
  • Signal peptide-containing molecules
    Publication number: 20050155089
    Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.
    Type: Application
    Filed: April 7, 2004
    Publication date: July 14, 2005
    Applicant: Incyte Corporation
    Inventors: Preeti Lal, Y. Tang, Gina Gorgone, Neil Corley, Karl Guegler, Mariah Baughn, Ingrid Akerblom, Janice Au-Young, Henry Yue, Chandra Patterson, Roopa Reddy, Jennifer Hillman, Olga Bandman